This video examines current research on the use of vaccines in low-grade glioma for the prevention of high-grade disease.
In this video, Hideho Okada, MD, PhD, of the University of California, San Francisco, discusses current research on the use of vaccines in low-grade glioma for the prevention of high-grade disease.
Okada gave a presentation on this topic at the 2017 American Association for Cancer Researcher (AACR) Annual Meeting, held April 1–5 in Washington, DC.
FDA Grants Orphan Drug Designation to Tirabrutinib in Primary CNS Lymphoma
March 29th 2023Investigators are assessing tirabrutinib, which received orphan drug designation from the FDA, as a treatment for patients with relapsed or refractory primary central nervous system lymphoma in the phase 2 PROSPECT study.
2 Clarke Drive
Cranbury, NJ 08512